Zusammenfassung
Der Alterungsprozess des Menschen verläuft individuell unterschiedlich und in verschiedenen Körperkompartimenten mit variabler Geschwindigkeit. Die alterungsspezifischen Veränderungen sind somit weniger chronologisch, sondern intrinsisch durch eine „endogene biologische Uhr“ geregelt (Balin 1994). Typische Altersveränderungen wie dünne, hängende und faltige Altershaut, Minderung von Vitalität und Mobilität, nachlassende Muskelkraft und Zunahme des Körperfetts, reduzierte sportliche, körperliche und geistige Leistungsfähigkeit sowie Minderung der Sexualität laufen nach einem individuell unterschiedlichen Zeitplan ab. Zahlreiche Organfunktionen reduzieren sich im Verlauf des Lebens nahezu linear und sind durch den Lebensstil wenig beeinflussbar. Andere Funktionen wie muskuläre und geistige Leistung sind stark von persönlichen Aktivitäten, körperlicher Beanspruchung sowie durch Anforderungen in Beruf und Freizeit abhängig und damit sehr von diesen Faktoren geprägt (⊡Abb. 9.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Baün AK (ed) (1994) Practical handbook of human biologic age determination. CRC-Press, Boca Raton
Beier W, Brehme KH, Wiegel D (Hrsg) (1973) Biophysikalische Aspekte des Alterns multizellulärer Systeme. VEB Thieme, Leipzig
Belsky JL, Moriyama IL, Fujita S, Kawamoto S (1967) Aging studies in atomic bomb survivors. Tech Rep REFR TR: 11–78
Curtis HG (ed) (1966) Biological mechanisms of aging. Thomas, Springfield
Dubina TL, Mintz AY, Zhuk EV (1984) Biological age and its estimation. III. Introduction of a correction to the multiplke regression model of biological age and assessment of biological age in sectional and longitudinal studies. Exp Gerontol 19: 133–141
Furakawa T (1994) Assessment of the adequacy of the multiregression method to estimate biological age. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC-Press, Boca Raton, pp 471–484
Furukawa T, Inoue M, Kajiya F et al. (1975) Takeda H, Abe H. Assessment of biological age by multiple regression analysis. J Gerontol 30:422–434
Heikkinen E, Kiiskinen A, Kayhty B, Rimpela M, Vuori I (1974) Assessment of biological age. Gerontologia 20:33–41
Hochschild R (1990) Can an Index of aging be constructed for evaluating treatments to retard aging rates? A 2462-person study. J Gerontol 45:187–214
Hofecker G, Skalicky M, Kment A, Niedermüller H (1980) Models of the biological age of the rat I. A factor model of age parameters. Mech Age Dev 14:345–360
Hofecker G, Skalicky M, Niedermüller H (1994) What animal experiments can teil us about human biological age. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC Press, Boca Raton, pp 419–435
Hollingsworth JW, Hashizume A, Jablon S (1965) Correlations between tests of aging in Hiroshima subjects — an attempt to define “Physiologie age”. Yale L Biol Med 36:11
Hollingsworth JW (1994) The Hiroshima studies of physiological age: A historical note. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC-Press, Boca Raton, pp 15–20
Hollmann W, Rost R, Mader A, Liesen H (1992) Altern, Leistungsfähigkeit und Training. Dtsch ärztebl 38: 3041–3054, 3116–3131, 1930–1937
Hutchins EB (1994) Aging and the aprasal of health risks. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC-Press, Boca Raton, pp 55–67
Meissner-Pöthig D, Michalak U, Beier W, Schulz J (1995) Interdisziplinäre Vitalitätsdiagnostik und functional age index in der gerontolgischen Prävention und Rehabilitation. ärztez Naturheilverf 8:578–587
Murray IM (1951) Assessmant of Physiologie age by combination of several criteria-vision, hearing, blood pressure and muscle force. J Gerontol 6:122–127
Orentreich N, Brindl JN, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551–559
Regelson W (1994) Aspects of quantitation of human aging. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC-Press, Boca Raton, pp 22–46
Ries W (1994) Determination of human biological age. In: Baiin AK (ed) Practical handbook of human biologic age determination. CRC Press, Boca Raton, pp 173–179
Römmler A (2002) Androgene für Mann und Frau. In: Römmler A, Wolf AS (Hrsg) Anti-Aging Sprechstunde, Teil 1: Leitfaden für Einsteiger. Congress Compact, Berlin, S. 103–138
Ruiz-Torres A, Agudo A, Vicent D, Beier W (1990) Measuring human aging using a two-compartmental mathematical model and the vitality coneept. Arch Gerontol Geriatr 10:69–82
Wolf AS (2002a) Biologische Altersparameter: Was können sie leisten? In: Moltz L, Römmler A, Wolf A, Klentze M (Hrsg) Anti-Aging Medizin 2001. Congress Compact, Berlin, S. 29–39
Wolf AS (2002b) Das Anti-Aging-Erstgespräch — Erstbefunde und Erstlabor. In: Römmler A, Wolf AS (Hrsg), Anti-Aging Sprechstunde, Teil 1: Leitfaden für Einsteiger. Congress Compact, Berlin, S. 25–38
Albert CM, Campos H, Stampfer MJ et al. (2002) Blood levels of longchain w-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113–1118
Appel LJ, Moore TJ, Obarzanek E et al., for the DASH Collaborative Research Group (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124
Ashley FW, Kannel WB (1974) Relation of weight change to changes in atherogenic traits. J Chronic Dis 27:103–114
Blair SN, Capuzzi DN, Gottlieb SO et al. (2000) Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 86:46–52
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999) Bodymass index and mortality in a prospective cohort of US adults. N Engl J Med 341:1097–1105
Daviglus ML, Stamler J, Orencia AJ et al. (1997) Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336: 1046–1053
De Caterina R, Massaro M (1999) Effects of diet and of dietary components on endothelial leucocyte adhesion molecules. Curr Atheroscler Reports 1:188–195
De Lorgeril M, Sälen P, Martin JL, Boucher F, Paillard F, De Leiris J (2002) Wine drinking and risks of cardiovascularcomplications after recent acute myocardial infarction. Circulation 106:1465–1469
De Lorgeril M, Sälen P, Martin J-L et al. (1998) Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med 158:1181–1187
De Lorgeril M, Sälen P, Martin J-L et al. (1999) Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 99:779–785
De Oliveira E, Siva ER, Scidman CE, Tian JJ et al. (1996) Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr. 64:712–717
Deutsche Gesellschaft für Ernährung (1991) Empfehlungen für die Nährstoffzufuhr 5. DGE, Frankfurt/Main
Di Castelnuovo A, Rotondo S, Lacoviello L et al. (2002) Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105:2836–2844
Feiton CV, Crook D, Davies MJ, Oliver MF (1994) Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet 344:1195–1196
Fräser GE, SabatE J, Beeson WL, Strahan TM (1992) A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study. Arch Int Med 152:1416–1424
Fuentes F, Lopez-Miranda J, Sanchez E et al. (2001) Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 134:1106–1114
Geleijnse JM, Launer LJ, Hofman A et al. (1999) Tea flavonoids may Protect against atherosclerosis: the Rotterdam Study. Arch Intern Med 159:2170–2174
GISSI-Prevenzione Investigators (1999) Dietary supplementation with w-3 polyunsaturated fatty acids and Vitamin E after myocardial Infarction. Lancet 354:447–455
Gohlke H, Kubier W, Mathes P et al. für die Deutsche Gesellschaft für Kardiologie (2001) Empfehlungen zur umfassenden Risikoverringerung für Patienten mit koronarer Herzerkrankung, Gefäßerkrankungen und Diabetes. Z Kardiol 90:148–149
Goldberg LJ, Mosca L, Piano MR et al. (2001) Wine and your heart: a science advisory for healthcare Professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 103:472–475
Goodfellow J, Bellamy MF, Ramsey MW, Jones CJH, Lewis MJ (2000) Dietary supplementation with omega-3-fatty acids improve systemic large arterial endothelial function in hypercholesterolemic subjects. JACC 35:265–270
Han TS, van Leer EM, Scidell JC, Lean MEJ (1995) Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Br Med J 311:1401–1405
HOPE Study (2000): Heart Outcome Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 342:154–160
Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomised placebo controlled trial. Lancet 360:7–22
Hines LM, Stampfer M, Ma J et al. (2001) Genetic Variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 344: 549–555
Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelmann D, Willett WC (2000) Prospective Study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 72:912–21
Hu FB, Stampfer MJ (1999) Nut consumption and risk of coronary heart disease: A review of epidemiologic evidence. Curr Atheroscler Reports 1:204–249
Hu FB, Stampfer MJ, Manson JE et al. (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337: 1491–1499
Hu FB, Stampfer MJ, Manson JE et al. (1998) Frequent nut consumption and risk of coronary heart disease. Br Med J 317:1341–1345
Hu FB, Stampfer MJ, Rimm E et al. (1999) A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281:1387–1394
Iso H, Rexrode KM, Stampfer MJ et al. (2001) Intake of fish and omega-3-fatty acids and risk of stroke in women. JAMA 285:304–312
Jenkins DJA, Kendali CWC, Marchie A et al. (2002) Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 106:1327–1332
Joshipura KJ, Ascherio A, Manson JE et al. (1999) Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282:1233–1239
Joshipura KJ, Hu FB, Manson JE et al. (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 134:1106–1114
Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1996) Twenty year dynamics of serum cholesterol levels in the middle aged population of eastern Finland. Ann Intern Med 125:713–722
Judd JT, Clevidence BA, Muesing RA et al. (1994) Dietary trans-fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 59:861–868
Kang JX, Leaf A (1996) Antiarrhythmic effects of polyunsaturated fatty acids — recent studies. Circulation 94:1774–1780
Katan MB, Grundy SM, Willett WC (1997) Beyond low fat diets. N Engl J Med 337:563–567
Kendali MJ, Lynch KP, Hjalmarson A et al. (1995) Beta-blockers and sudden cardiac death. Ann Intern Med 123:358–367
Khaw K-T, Bingham S, Welch A, Lüben R, Wareham N, Oakes S, Day N (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 357:657–663
Krauss RM, Eckel RH, Howard B et al. (2000) AHA Dietary Guidelines: Revision 2000. A Statement for healthcare Professionals from the Nutrition Comitee of the American Heart Association. Circulation 102:2284–2299
Kris-Etherton PM, for the Nutrition Committee (1999) Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 100:1253–1258
Kris-Etherton P et al. for the Nutrition Committee, Population Science Committee, and Clinical Science Committee of the American Heart Association (2001) Lyon Diet Heart Study — Benefits of a mediterranean-style, national cholesterol education program / American Heart Association Step I dietary pattern on cardiovascular disease. Circulation 103:1823–5
Kushi LH, Lenart EB, Willett WC (1995) Health implications of mediterrean diets in light of contemporary knowledge. Plant foods and dairy products. Meat, wine, fats, and oils. Am J Clin Nutr 61 (Suppl): 1407S–1427S
Lee TH, Hoover RL, Williams JD et al. (1985) Effect of dietary enrichment with eicosapentaenoic and docosaheaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophile function. N Engl J Med 312:1217–1224
Lemaitre RN, King IB, Raghunathan TE et al. (2002) Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105:697–701
Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE (2002) A Prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coli Cardiol 39:49–56
Liu SM, Stampfer MU, Hu FB et al. (1999) Whole grain consumption and risk of coronary heart disease: results from Nurses’ Health Study. Am J Clin Nutr 70:412–419
Lonn EM, Yusuf S, Dzavik V et al. (2001) Effects od ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and Vitamin E (SECURE). Circulation 103:919–925
Marchioli R, Barzi F, Bomba E et al. (2002) Early protection against sudden death by w-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’lnfarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903
Mezzano D, Munoz X, Martinez C et al. (1999) Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost 81:913–917
Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E (1995) Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333: 1308–1312
Miller ER, Appel LJ, Risby TH (1998) Effect of dietary patterns on measures of lipid peroxidation — Results from a clinical trial. Circulation 98:2390–2395
Miller GJ, Cruickshank JK, Ellis LH et al. (1989) Fat consumption and factor VII coagulant activity in middle aged men. An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 78:19–24
Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA (2002) Tea consumption and mortality after acute myocardial infarction. Circulation 105:2476–2480
Ornish D, Brown SE, Scherwitz LW et al. (1990) Can lifestyle changes reverse coronary heart disease? Lancet 336:129–133
Pietinen P, Rimm EB, Korhonen P et al. (1996) Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: The Alpha-Tocopherol, Beta-Carotene Cancer prevention study. Circulation 94:2720–2727
Quesenberry CP, Caan B, Jacobson A (1998) Obesity, health service use and health care costs among members of a health maintenance Organization. Arch Intern Med 158:466–472
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Wille,WC (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343:16–22
Stokes J (1988) Dyslipidemia asa risk factor for cardiovascular disease and untimely death: The Framingham Study. In: Stokes J, Mancini M (eds) Atherosclerosis reviews, vol 18. Raven, New York
Tribble DL for the Nutrition Committee (1999) Antioxidant Consumption and risk of coronary heart disease: emphasis on Vitamin C, Vitamin E, and ß-carotene — a Statement for healthcare Professionals from the American Heart Association. Circulation 99: 591–595
Wenzel H (1989) Omega-3-Fettsäuren in unserer Ernährung — Grundlagen, Empfehlungen, Fragen. In: Swobodnik W, Wechsler JG (Hrsg) Omega-3-Fettsäuren. Grundlagen und klinische Anwendung. Edition medizin, Weinheim, S 21
Wille, WC, Dietz WH, Colditz GA (1999) Primary care: guidelines for healthy weight (review). N Engl J Med 341:427–434
Woolett LA, Spadey DK, Dietschy JM (1989) Mechanisms by which triacylated triglycerols elevate the plasma low density lipoprotein cholesterol concentration in hamsters: differential effects of fatty acid chain length. J Clin Invest 84:119–128
Yu-Poth S, Zhao G, Etherton T et al. (1999) Effects of national cholesterol education program’s step i and step ii dietary Intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutrition 69:632–646
Zambon D, Sabate J, Munoz S et al. (2000) Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women — a randomized crossover trial. Ann Intern Med 132:538–46
Bergstrom A, Terry P, Lindblad P et al. (2001) Physical activity and risk of renal cell Cancer. Int J Cancer 92:155–157
Dimeo F, Fetscher S, Lange W et al. (1997a) Effects of aerobic exercise on the physical Performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 90: 3390–3394
Dimeo F, Tilmann MH, Bertz H et al. (1997b) Aerobic exercise in the rehabilitation of Cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 79: 1717–1722
Dimeo F, Rumberger BG, Keul J (1998) Aerobic exercise as therapy for Cancer fatigue. Med Sci Exer 30:475–578
Dimeo F, Thiel E, Böning D (1999) Körperliche AktivitÄt in der Rehabilitation onkologischer Patienten. Dtsch Ärztebl 20:1340–1345
Friedenreich CM (2001) Physical activity and cancer prevention: from observational to Intervention research. Cancer Epidemiol Biomarkers Prev 10:287–301
Friedenreich CM, Thune I (2001) A review of physical activity and prostate cancer risk. Cancer Causes Control 12:461–475
Greenwald P (2002) Cancer prevention clinical trials. Clin Oncol 20 (Suppl 18): 14S–22S
Heitkamp HC (1998) Endogene Opioie und körperliche AktivitÄt. Z Sportmedizin 1:118–124
Jadeski L, Hoffmann-Goetz L (1996) Exercise an in vivo natural cytotoxicity against tumor cells of varying metastatic capacity. Clin Exp Metastasis 14:138–144
Klotz T., (1998) Der frühe Tod des starken Geschlechts. Cuvillier, Göttingen
Klotz T., (2002) Fitness im Alter. Urologe A 41:315–317
MacNeil B, Hoffmann-Goetz L., (1993) Effect of exercise on antural cytotoxicity and pulmonary tumor metastases in mice. Med Sci Sports Exer 25:922–928
McTiernan A, Ulrich C, Slate S, Potter J (1998) Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 9:487–509
Moyad MA (2001) Review ot potential risk factors for kidney (renal cell) cancer. Semin Urol Oncol 19:280–293
Sommer F (2001) Sport und Urologie. Urologe B 41:163
Sommer F, Klotz T (2002) Wege zur körperlichen Fitness im MÄnnerleben. In: Jacobi GH (Hrsg.) Praxis der MÄnnergesundheit. Thieme, Stuttgart, New York
Sommer F et al. (2002) Sport und Bewegung in der PrÄvention Urologischer Erkrankungen. Urologe B 42:297–305
Schmitz-DrÄger BJ, Jankevicius F, Otto T (1995) Prognostic factors for predicting the sucess of immunotherapy in metastatic renal cell Carcinoma. Urologe A 34:195–199
Schwartz AL (1998) Patterns of exercise and fatigue in physically active cancer survivors. Oncol Nurs Forum 25:485–491
Thune I, Furberg AS (2001) Physical activity and cancer risk: doseresponse and cancer, all sites and site-speeific. Med Sci Sports Exerc 33 (Suppl 6): S530–550
Trinkler FB (1995) Screening des Prostatakarzinoms. Ther Umschau 6:393–398
Peters C, Mucha C, Michna H, Lötzerich C (1998) Vergleichende Untersuchung zum Immunstatus trainierter und untrainierter Junioren und Senioren. Z Sportmedizin 1:111–114
Uhlenbruck G, Order U (1991) Can endurance sports stimulate immune mechanisms against cancer and metastasis? Int J Sports Med 12 (Suppl): S63–S68
Uhlenbruck G, Lötzerich C, Peters C, Ledvina I (1992) Sport als zusÄtzliche Therapiemöglichkeit in der Krebsnachsorge. In: Klippel KF (Hrsg): Integrative Betreuung des chronisch kranken Krebspatienten. Kongressband vom V.Stuttgarter Immuntherapie-Symposium. Mack, Schönaich
Wannamethee SG, Shaper AG, Walker M (2001) Physical activity and riskof cancer in middle-aged men. Br J Cancer 85:1311–1316
Rights and permissions
Copyright information
© 2004 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Wolf, A.S. et al. (2004). Der ganze Patient. In: Männersprechstunde. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18705-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-18705-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00915-3
Online ISBN: 978-3-642-18705-6
eBook Packages: Springer Book Archive